Improved Late Clinical Safety With Zotarolimus-Eluting Stents Compared With Paclitaxel-Eluting Stents in Patients With De Novo Coronary Lesions

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations

Medicine, Cardiology, Health Technology Assessment +13

Pathology of Drug-Eluting Stents in Humans

Michael Joner, Aloke V. Finn, Andrew Farb et al. · Journal of the American College of Cardiology · 2006 · 2.7K citations

Medicine, Cardiology, Pathology +11

Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents

Gregg W. Stone, Jeffrey W. Moses, Stephen G. Ellis et al. · New England Journal of Medicine · 2007 · 1.6K citations · Full text

Medicine, Cardiology, Internal Medicine +15

Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden

Bo Lagerqvist, Stefan James, Ulf Stenestrand et al. · New England Journal of Medicine · 2007 · 1.2K citations · Full text

Medicine, Anesthesiology, Interventional Cardiology +1

Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement

John A. Spertus, Richard Kettelkamp, Clifton Vance et al. · Circulation · 2006 · 858 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17